

( (S (NP-SBJ (NP Two rival bidders)
             (PP for
                 (NP Connaught BioSciences)))
     (VP extended
         (NP their offers
             (S (NP-SBJ *)
                (VP to
                    (VP acquire
                        (NP the Toronto-based vaccine manufacturer)))))
	 (NP-TMP Friday))
     .))
( (S (NP-SBJ (NP Institut Merieux S.A.)
             ,
             (SBAR (WHNP-1 which)
                   (S (NP-SBJ *T*-1)
                      (VP offered
                          (NP (NP (NP (QP 942 million) 
				      Canadian dollars)
                                  (PRN -LRB-
				       (NP (QP US$ 801.2 million)
					   *U*)
				       -RRB-))
                              , 
			      or
                              (NP (NP C$ 37 *U*)
                                  (NP-ADV a share)))
                          (PP-CLR for
				  (NP Connaught)))))
             ,)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP would
                      (VP extend
                          (NP (NP its bid)
                              ,
                              (ADJP due
                                    (S (NP-SBJ *)
                                       (VP to
                                           (VP expire
					       (NP-TMP last Thursday)))))
			      ,)
                          (PP-CLR to
				  (NP Nov. 6)))))))
     .))
( (S (NP-SBJ-1 (NP A 
		   (ADJP C$ 30-a-share *U*) 
		   bid)
               (PP by
                   (NP (NP (NP Ciba-Geigy Ltd.)
                           ,
                           (NP (NP a pharmaceutical company)
                               (VP based
                                   (NP *)
                                   (PP-LOC-CLR in
					       (NP (NP Basel)
						   ,
						   (NP Switzerland))))))
                       , 
		       and
                       (NP (NP California-based Chiron Corp.)
                           ,
                           (NP a bioresearch concern)
                           ,))))
     (VP was
         (VP extended
             (NP *-1)
             (PP-CLR to
		     (NP Nov. 16))))
     .))
( (S (NP-SBJ It)
     (VP had
         (VP been
             (ADJP-PRD due
		       (S (NP-SBJ *)
			  (VP to
			      (VP expire
				  (NP-TMP Friday evening)))))))
     .))
( (S (NP-SBJ Merieux)
     (ADVP-TMP previously)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP would
                      (VP ensure
                          (SBAR 0
                                (S (NP-SBJ its bid)
                                   (VP remained
                                       (ADJP-PRD open)
				       (PP pending
					   (NP (NP a final decision)
					       (PP by
						   (NP Canadian regulators))
					       (PP on
						   (SBAR whether
							 (S (NP-SBJ *)
							    (VP to
								(VP approve
								    (NP the takeover))))))))))))))))
     .))
( (S (NP-SBJ-1 (NP Merieux)
               ,
               (NP (NP a vaccine and bioresearch firm)
                   (VP based
                       (NP *)
                       (PP-LOC-CLR in
				   (NP (NP Lyon)
				       ,
				       (NP France)))))
               ,)
     (VP is
         (VP controlled
             (NP *-1)
             (NP-ADV 50.1 %)
             (PP by
                 (NP-LGS state-owned Rhone Poulenc S.A))))
     .))
( (S (NP-SBJ The Canadian government)
     (ADVP-TMP previously)
     (VP said
         (SBAR 0
               (S (NP-SBJ-2 (NP Merieux 's)
			    bid)
                  (VP did 
		      n't
                      (VP (VP offer
                              (NP enough `` net benefit '')
                              (PP-CLR to
				      (NP Canada))
                              (S-PRP (NP-SBJ-1 *-2)
				     (VP to
					 (VP be
					     (VP approved
						 (NP *-1))))))
                          , 
			  and
                          (VP gave
                              (NP-3 Merieux)
                              (NP an
                                  (X until 
				     mid-November))
                              (S-PRP (NP-SBJ *-3) 
				     (VP to
					 (VP submit
					     (NP additional information))))))))))
     .))
( (S (NP-SBJ Merieux officials)
     (VP said
         (NP-TMP last week)
         (SBAR that
               (S (NP-SBJ they)
                  (VP are
                      (ADJP-PRD `` highly confident ''
				(SBAR 0
				      (S (NP-SBJ-1 the offer)
					 (VP will
					     (VP be
						 (VP approved
						     (NP *-1)
						     (SBAR-TMP once
							       (S (NP-SBJ it)
								  (VP submits
								      (NP (NP details)
									  (PP of
									      (NP its proposed investments)))
								      (PP-CLR to
									      (NP federal regulators)))))))))))))))
     .))
( (S (NP-SBJ Both offers)
     (VP are
         (ADJP-PRD conditional
		   (PP on
		       (NP (NP regulatory approvals)
			   and
			   (S-NOM (NP-SBJ enough shares)
				  (VP being
				      (VP tendered
					  (S-PRP (NP-SBJ *)
						 (VP to
						     (VP give
							 (NP the bidders)
							 (NP (NP a majority)
							     (PP of
								 (NP (NP (NP Connaught 's)
									 shares)
								     (ADJP outstanding))))))))))))))
     .))
( (S (NP-SBJ (NP Institut Merieux)
             ,
             (SBAR (WHNP-1 which)
		   (S (NP-SBJ *T*-1)
		      (ADVP-TMP already)
		      (VP holds
                          (NP (NP a 
				  (ADJP 12.5 %) 
				  stake)
                              (PP in
                                  (NP Connaught))))))
             ,)
     (VP said
         (SBAR that
               (S (PP-TMP at
			  (NP (NP the close)
			      (PP of
				  (NP business))))
		  (NP-TMP Thursday)
                  ,
                  (NP-SBJ-2 (NP (NP 5,745,188 shares)
				(PP of
				    (NP Connaught)))
			    and
			    (NP (NP (ADJP (QP C$ 44.3 million)
					  *U*)
				    face amount)
				(PP of
				    (NP debentures))
				,
				(ADJP convertible
				      (PP into
					  (NP 1,826,596 common shares)))
				,))
                  (VP had
                      (VP been
                          (VP tendered
			      (NP *-2)
                              (PP-CLR to
				      (NP its offer))))))))
     .))
( (S (PP-TMP At
	     (NP (NP the close)
		 (PP of
		     (NP business))))
     (NP-TMP Thursday)
     ,
     (NP-SBJ Ciba-Geigy
	     and
	     Chiron)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 11,580 common shares)
                  (VP had
                      (VP been
                          (VP tendered
			      (NP *-1)
                              (PP-CLR to
				      (NP their offer))))))))
     .))
( (S (PP-TMP At
	     (NP last report))
     ,
     (NP-SBJ Connaught)
     (VP had
         (NP (NP (QP 21.8 million) 
		 shares)
             (ADJP outstanding)))
     .))
( (S (ADVP Separately)
     ,
     (NP-SBJ the Ontario Supreme Court)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP will
                      (VP postpone
                          (ADVP-TMP indefinitely)
                          (NP (NP a ruling)
                              (PP on
                                  (NP (NP the lawsuit)
                                      (VP launched
                                          (NP *)
                                          (PP by
                                              (NP-LGS (NP the University)
                                                      (PP of
                                                          (NP Toronto))))
                                          (PP-CLR against
						  (NP Connaught))
                                          (PP in
                                              (NP (NP connection)
                                                  (PP with
                                                      (NP the Merieux bid)))))))))))))
     .))
( (S (PP-LOC In
	     (NP (NP a statement)
		 (VP prepared
		     (NP *)
		     (PP by
			 (NP-LGS lawyers))
		     (PP-CLR for
			     (NP (NP the university)
				 and
				 (NP Connaught))))))
     ,
     (NP-SBJ the parties)
     (VP said
         (SBAR 0
               (S (NP-SBJ they)
                  (VP agreed
                      (SBAR that
                            (S (PP-PRP as
				       (NP (NP a result)
					   (PP of
					       (S-NOM (NP-SBJ *)
						      (VP reaching
							  (NP a 
							      (ADJP (QP C 415 million) 
								    *U*) 
							      research accord))))))
                               , 
			       ``
                               (NP-SBJ (NP It)
				       (SBAR *EXP*-1))
			       (VP is
				   (ADJP-PRD unnecessary)
				   (SBAR-1 that
					   (S (NP-SBJ there)
					      (VP be
						  (NP-PRD (NP a judgment)
							  (PP on
							      (NP (NP the merits)
								  -LCB-
								  (PP of
								      (NP the case))
								  -RCB-)))
						  (PP-TMP at
							  (NP this time))))))))))))
     . 
     ''))
( (S (NP-SBJ (NP Lawyers)
             (PP for
                 (NP the two sides)))
     (VP were 
	 n't
         (ADVP-TMP immediately)
         (ADJP-PRD available
		   (PP for
		       (NP comment))))
     .))
( (S (NP-SBJ The university)
     (VP had
         (VP sought
             (NP (NP an injunction)
                 (VP blocking
                     (NP-1 (NP Connaught 's)
			   board)
                     (PP-CLR from
			     (NP (S-NOM (NP-SBJ *-1)
					(VP recommending
					    or
					    supporting
					    (NP (NP an offer)
						(PP for
						    (NP the company))
						(PP by
						    (NP Merieux)))))))))))
     .))
